Quantum BioPharma Ltd.
QNTM
$3.89
-$0.16-3.95%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 2.21M | 2.17M | 4.04M | 4.16M | 1.62M |
| Depreciation & Amortization | 127.40K | 129.40K | 145.30K | 141.40K | 129.70K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.97M | 2.37M | 4.68M | 4.85M | 3.40M |
| Operating Income | -2.97M | -2.37M | -4.68M | -4.85M | -3.40M |
| Income Before Tax | -13.75M | -3.70M | -4.75M | -9.77M | -8.74M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -13.75M | -3.70M | -4.75M | -9.77M | -8.74M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 193.30K | 676.60K | -571.40K | 513.30K | 163.20K |
| Net Income | -13.56M | -3.03M | -5.32M | -9.25M | -8.58M |
| EBIT | -2.97M | -2.37M | -4.68M | -4.85M | -3.40M |
| EBITDA | -2.84M | -2.24M | -4.53M | -4.71M | -3.27M |
| EPS Basic | -3.02 | -0.79 | -1.40 | -3.06 | -3.47 |
| Normalized Basic EPS | -1.83 | -0.85 | -0.96 | -1.83 | -2.19 |
| EPS Diluted | -3.02 | -0.79 | -1.40 | -3.06 | -3.47 |
| Normalized Diluted EPS | -1.83 | -0.85 | -0.96 | -1.83 | -2.19 |
| Average Basic Shares Outstanding | 4.49M | 3.83M | 3.80M | 3.02M | 2.48M |
| Average Diluted Shares Outstanding | 4.49M | 3.83M | 3.80M | 3.02M | 2.48M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |